Skip to main content
. 2024 Jul 12;22:412. doi: 10.1186/s12951-024-02683-2

Fig. 7.

Fig. 7

Biocompatibility and metabolic pathway of GSH-CDs in mice. (a) In vivo fluorescence images of GSH-CDs at different time intervals. (b) Trends of weight change within 30 days after tail vein injection of PBS or GSH-CDs. (c) HE staining of major organs (heart, liver, spleen, lungs and kidneys) in the PBS and GSH-CD groups after intravascular injection (Scale bar = 200 μm). (d) Hematological and biochemical indexes of each group